Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases
暂无分享,去创建一个
Uri Raviv | Yechezkel Barenholz | Haim Ovadia | Efrat Sasson | Y. Barenholz | U. Raviv | H. Ovadia | K. Turjeman | E. Sasson | Keren Turjeman | Nahum Allon | Y. Schilt | Yaelle Bavli | Pablo Kizelsztein | Yaelle Schilt | Tamar Blumenfeld Katzir | Yaelle Bavli | N. Allon | P. Kizelsztein
[1] M. El-Sabaawi. Breakdown of Will , 2002 .
[2] J. Beijnen,et al. Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis. , 2011, International journal of pharmaceutics.
[3] H. Ninomiya,et al. Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth , 1993, The Journal of cell biology.
[4] G. Burmester,et al. A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. , 1998, Arthritis and rheumatism.
[5] S. Hahn,et al. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. , 1991, Archives of biochemistry and biophysics.
[6] C. Kennard,et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS , 1989, Neurology.
[7] A. P. Hammersley,et al. Two-dimensional detector software: From real detector to idealised image or two-theta scan , 1996 .
[8] Y. Barenholz,et al. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. , 2005, Chemistry and physics of lipids.
[9] H. Lassmann,et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.
[10] A. Sigal,et al. Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis , 2009, Journal of Neuroimmunology.
[11] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[12] Bernhard Hemmer,et al. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. , 2007, Brain : a journal of neurology.
[13] B. D. Anderson,et al. Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate. , 1981, Journal of pharmaceutical sciences.
[14] A. Lorenzo,et al. BRAIN VASCULAR PERMEABILITY TO I125 GAMMA GLOBULIN AND LEUKOCYTES IN ALLERGIC ENCEPHALOMYELITIS , 1967, Journal of neuropathology and experimental neurology.
[15] R. Gold,et al. Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: Long-term protective effects and enhanced efficacy of methylprednisolone formulations , 2008, Experimental Neurology.
[16] Berislav V. Zlokovic,et al. New therapeutic targets in the neurovascular pathway in Alzheimer’s disease , 2008, Neurotherapeutics.
[17] P. Sanberg,et al. Free radical damage and oxidative stress in Huntington's disease. , 1996, The Journal of the Florida Medical Association.
[18] C. Pozzilli,et al. Corticosteroids treatment , 2004, Journal of the Neurological Sciences.
[19] Y. Barenholz,et al. Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing Mice , 1996, Pharmaceutical Research.
[20] Yechezkel Barenholz,et al. Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids , 2011, PloS one.
[21] H P Hartung,et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. , 1996, Brain : a journal of neurology.
[22] B E Kendall,et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.
[23] Gijs Kooij,et al. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[24] Amiram Goldblum,et al. Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[25] Hans Lassmann,et al. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.
[26] S. Leibowitz,et al. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. , 1972, Immunology.
[27] B. P. Doctor,et al. A new liposome-based gene delivery system targeting lung epithelial cells using endothelin antagonist. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[28] L. Candelise,et al. Steriods for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials , 2000, Journal of Neurology.
[29] D. Dick,et al. Intravenous methylprednisolone for multiple sclerosis in relapse. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[30] G. R. Bartlett. Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.
[31] Tal Ben-Nun,et al. X+: a comprehensive computationally accelerated structure analysis tool for solution X‐ray scattering from supramolecular self‐assemblies , 2010 .
[32] M. Ebadi,et al. Oxidative stress and antioxidant therapy in Parkinson's disease , 1996, Progress in Neurobiology.
[33] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[34] H. Reichardt,et al. Glucocorticoids in the control of neuroinflammation , 2007, Molecular and Cellular Endocrinology.
[35] H. Miller,et al. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.). , 1961, Lancet.
[36] S. Karlik,et al. Correlation between MRI and clinico-pathological manifestations in Lewis rats protected from experimental allergic encephalomyelitis by acylated synthetic peptide of myelin basic protein. , 1999, Magnetic resonance imaging.
[37] Mark S. Freedman,et al. Therapy of MS , 2010, Clinical Neurology and Neurosurgery.
[38] A. Thompson,et al. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[39] Richard Buist,et al. Magnetic resonance imaging of blood–spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis , 2007, Magnetic resonance in medicine.
[40] J. Pe’er,et al. Nitroxide stable radical suppresses autoimmune uveitis in rats. , 1999, Free radical biology & medicine.
[41] C. F. Barlow. A STUDY OF ABNORMAL BLOOD‐BRAIN PERMEABILITY IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS , 1956, Journal of neuropathology and experimental neurology.
[42] D. Brann,et al. Emerging diversities in the mechanism of action of steroid hormones , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[43] Roi Asor,et al. Effect of capsid confinement on the chromatin organization of the SV40 minichromosome , 2012, Nucleic acids research.
[44] R. Gold,et al. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. , 2003, Brain : a journal of neurology.
[45] W. Mcdonald,et al. Patterns of blood-brain barrier breakdown in inflammatory demyelination. , 1991, Brain : a journal of neurology.
[46] W. Norde,et al. Physical Chemistry of Biological Interfaces , 2000 .
[47] K. Nicolay,et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. , 2004, Brain : a journal of neurology.
[48] A. Sigal,et al. Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[49] R. Brasch,et al. Nitroxyl spin label contrast enhancers for magnetic resonance imaging. Studies of acute toxicity and mutagenesis. , 1984, Investigative radiology.
[50] R. Newcombe,et al. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[51] R. Gold,et al. Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders , 2001, Journal of Neuroimmunology.
[52] B E Kendall,et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.
[53] R. Gold,et al. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis , 2006, Expert review of neurotherapeutics.
[54] W. Markesbery,et al. Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.
[55] V. Wee Yong,et al. Inflammation in Neurological Disorders: A Help or a Hindrance? , 2010, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[56] Y. Barenholz,et al. Influence of lipid composition on the thermotropic behavior and size distribution of mixed cationic liposomes. , 2011, Journal of colloid and interface science.
[57] R. Herndon,et al. The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord. , 1986, Archives of neurology.
[58] J. Sarsero,et al. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia , 2003, The journal of gene medicine.
[59] R. Tattersall,et al. Diabets in identical twins , 1972 .
[60] Wilfred D. Stein,et al. Transport and Diffusion Across Cell Membranes , 1986 .
[61] D. Grahame,et al. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[62] S. Croul,et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis , 2000, Journal of the Neurological Sciences.
[63] Yechezkel Barenholz,et al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. , 2008, Arthritis and rheumatism.
[64] Robert H. Brown,et al. Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.
[65] O. Paulson,et al. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat , 1984, Brain Research.
[66] B. Bergamasco,et al. High‐dose intravenous methylprednisolone in the treatment of multiple sclerosis , 1986, Neurology.
[67] G. Johnson,et al. Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[68] Alexander Golbraikh,et al. Quantitative structure-property relationship modeling of remote liposome loading of drugs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[69] N. Stanietsky,et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.
[70] M. Masserini,et al. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. , 2011, Journal of biotechnology.
[71] W. Waldhäusl,et al. G-protein-coupled glucocorticoid receptors on the pituitary cell membrane , 2005, Journal of Cell Science.
[72] Yechezkel Barenholz,et al. Liposome application: problems and prospects , 2001 .
[73] J. Sturtevant,et al. High-Sensitivity Differential Scanning Calorimetry in the Study of Biomembranes and Related Model Systems , 1978 .
[74] S. Hahn,et al. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage. , 1997, Free radical biology & medicine.
[75] M. Pender,et al. Corticosteroid treatment of experimental autoimmune encephalomyelitis in the Lewis rat results in loss of Vβ8.2+ and myelin basic protein-reactive cells from the spinal cord, with increased total T-cell apoptosis but reduced apoptosis of Vβ8.2+ cells , 1996, Journal of Neuroimmunology.
[76] W. Degraff,et al. Nitroxide-mediated protection against X-ray- and neocarzinostatin-induced DNA damage. , 1992, Free radical biology & medicine.
[77] Yechezkel Barenholz,et al. The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[78] Tal Ben-Nun,et al. Solution X-ray scattering form factors of supramolecular self-assembled structures. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[79] S. Cook,et al. Effect of high–dose intravenous steriod administration on contrast‐enhancing computed tomographic scan lesions in multiple sclerosis , 1984 .
[80] Bradley F. Chmelka,et al. Current Opinion in Colloid & Interface Science , 2009 .